Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients

Volume 51, Issue 11 p. 1170-1171

LETTER TO THE EDITOR

Nobuharu Tamaki,

Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

NAFLD Research Center, Department of Medicine, University of California San Diego, La Jolla, California, USA

Search for more papers by this authorMasayuki Kurosaki,

Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

Search for more papers by this authorSakura Kirino,

Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

Search for more papers by this authorNamiki Izumi,

Corresponding Author

Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

Correspondence

Namiki Izumi, President of Musashino Red Cross Hospital Director, Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital 1-26-1 Kyonan-cho, Musashino-shi, Tokyo 180-8610, Japan.

Email: izumi012@musashino.jrc.or.jp

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.

Comments (0)

No login
gif